EDWIN HEIDELBERGER: Open Payments
NPI 1821070970 · SPRINGVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 37 payments from 15 companies in 2025. Trend: 2023 $682 · 2024 $592 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $150 |
| ABBVIE INC. | 5 | $100 |
| GlaxoSmithKline, LLC. | 5 | $96 |
| Exact Sciences Corporation | 3 | $74 |
| PFIZER INC. | 3 | $68 |
| Amgen Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Edwards Lifesciences Corporation | 1 | $22 |
Products named: SHINGRIX, Cologuard Collection Kit, Ozempic, UBRELVY, VRAYLAR, Wegovy, JARDIANCE, OTEZLA.
Industry payments across NY — which companies pay providers there.
